Concepedia

Ralf Kolassa

RK

4

Publications

302

Citations

4

H-Index

2017

Active since

Affiliations

Medtronic (United States)(Current)

Wellcome/MRC Institute of Metabolic Science

Medtronic (Switzerland)

Medtronic (Germany)

Medtronic (Netherlands)

Ralf Kolassa is an author at Medtronic (United States) specializing in outcomes research, medicine, and diabetes.

Top concepts

Publications per year

2017–2023

4

Publications

4

Advanced hybrid closed loop therapy versus conventional treatment in adults with type 1 diabetes (ADAPT): a randomised controlled study

Pratik Choudhary, Ralf Kolassa, Winfried Keuthage et al. · The Lancet Diabetes & Endocrinology · 2022 · 179 citations

, , +8

Discrepancies Between Blood Glucose and Interstitial Glucose—Technological Artifacts or Physiology: Implications for Selection of the Appropriate Therapeutic Target

Thorsten Siegmund, Lutz Heinemann, Ralf Kolassa et al. · Journal of Diabetes Science and Technology · 2017 · 98 citations · Full text

Twelve‐month results of the ADAPT randomized controlled trial: Reproducibility and sustainability of advanced hybrid closed‐loop therapy outcomes versus conventional therapy in adults with type 1 diabetes

N. Shannon, Javier Castañeda, Pratik Choudhary et al. · Diabetes Obesity and Metabolism · 2023 · 15 citations · Full text

The Development of New Composite Metrics for the Comprehensive Analytic and Visual Assessment of Hypoglycemia Using the Hypo-Triad

Andreas Thomas, John Shin, Boyi Jiang et al. · Journal of Diabetes Science and Technology · 2017 · 10 citations · Full text

Rows per page

1–4 of 4